BioPharmSignal logoBioPharmSignal

Biotech News

Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2025 Results Report

Progyny (PGNY)ProgynyEarnings

NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, will report its financial results for the quarterly period and full year ended December 31, 2025, after the close of the market on Thursday, February 26, 2026.

Open original release

Related news

PGNYProgyny2026-04-23 17:56 EST

Progyny, Inc. Announces Details for Its First Quarter 2026 Results Report

PGNYProgyny2026-02-26 21:01 EST

Progyny, Inc. Announces Fourth Quarter 2025 Results

COOThe Cooper Companies2025-11-04 21:15 EST

CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2025

SERASera Prognostics2026-03-18 20:05 EST

SERA PROGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS

TDOCTeladoc2026-02-25 21:05 EST

Teladoc Health Reports Fourth Quarter and Full Year 2025 Results

COOThe Cooper Companies2025-12-04 21:15 EST

CooperCompanies Announces Fourth Quarter and Full Year 2025 Results

HSTMHealthStream2026-02-23 21:30 EST

HealthStream Announces Fourth Quarter & Full-Year 2025 Results

HSTMHealthStream2026-02-12 14:25 EST

HealthStream to Host Fourth Quarter & Full-Year 2025 Earnings Conference Call

SERASera Prognostics2026-03-04 13:05 EST

SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF FOURTH QUARTER AND FISCAL YEAR 2025 FINANCIAL RESULTS ON MARCH 18, 2026

TDOCTeladoc2026-02-05 21:30 EST

Teladoc Health to Announce Fourth Quarter 2025 Financial Results

View all latest news

Progyny

Progyny is a fertility and family-building benefits company serving employers and their members through specialized reproductive-health services.

Recent company news

PGNYProgyny2026-05-28 13:04 EST

New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System

PGNYProgyny2026-05-26 12:00 EST

Progyny, Inc. Announces Share Repurchase Program

PGNYProgyny2026-05-11 14:57 EST

Progyny, Inc. to Present at BofA Securities 2026 Health Care Conference

PGNYProgyny2026-05-07 20:01 EST

Progyny, Inc. Announces First Quarter 2026 Results

PGNYProgyny2026-04-23 17:56 EST

Progyny, Inc. Announces Details for Its First Quarter 2026 Results Report

Stock data

Close
31.59 USD
Market cap
1.97B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States